6778456|t|Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders.
6778456|a|A possible antimanic property of the GABA-ergic anticonvulsant valproate was examined by use of a double-blind placebo-controlled ABA design in 5 acutely ill manic patients. In 4 cases a marked improvement was observed after valproate medication whereas one patient showed no response. Seven further patients with frequently recurrent episodes of a manic or maniform schizoaffective psychosis, irresponsive to lithium prophylaxis, were chronically treated with valproate in combination with low doses of lithium (one case only with valproate). Over an observation period of 1 1/2-3 years none of the patients exhibited a relapse. It is proposed that, in general, GABA-ergic anticonvulsants possess antimanic properties and that the specific antimanic effect of lithium is due to a GABA-ergic mode of action. The possible role of GABA-systems in affective disorders and in organic types of psychoses (e.g.,porphyria-psychosis, delirium tremens) is discussed on the basis of pharmacopsychiatric considerations.
6778456	10	26	sodium valproate	Chemical	MESH:D014635
6778456	30	35	mania	Disease	MESH:D001714
6778456	41	45	GABA	Chemical	MESH:D005680
6778456	60	79	affective disorders	Disease	MESH:D019964
6778456	118	122	GABA	Chemical	MESH:D005680
6778456	144	153	valproate	Chemical	MESH:D014635
6778456	239	244	manic	Disease	MESH:D001714
6778456	245	253	patients	Species	9606
6778456	306	315	valproate	Chemical	MESH:D014635
6778456	339	346	patient	Species	9606
6778456	381	389	patients	Species	9606
6778456	430	435	manic	Disease	MESH:D001714
6778456	448	473	schizoaffective psychosis	Disease	MESH:D011618
6778456	491	498	lithium	Chemical	MESH:D008094
6778456	542	551	valproate	Chemical	MESH:D014635
6778456	585	592	lithium	Chemical	MESH:D008094
6778456	613	622	valproate	Chemical	MESH:D014635
6778456	681	689	patients	Species	9606
6778456	744	748	GABA	Chemical	MESH:D005680
6778456	842	849	lithium	Chemical	MESH:D008094
6778456	862	866	GABA	Chemical	MESH:D005680
6778456	910	914	GABA	Chemical	MESH:D005680
6778456	926	945	affective disorders	Disease	MESH:D019964
6778456	970	979	psychoses	Disease	MESH:D011618
6778456	996	1005	psychosis	Disease	MESH:D011618
6778456	1007	1023	delirium tremens	Disease	MESH:D000430
6778456	Negative_Correlation	MESH:D008094	MESH:D011618
6778456	Negative_Correlation	MESH:D008094	MESH:D001714
6778456	Association	MESH:D005680	MESH:D019964
6778456	Negative_Correlation	MESH:D014635	MESH:D001714
6778456	Association	MESH:D005680	MESH:D011618
6778456	Negative_Correlation	MESH:D005680	MESH:D008094
6778456	Cotreatment	MESH:D008094	MESH:D014635
6778456	Association	MESH:D005680	MESH:D000430

